Selective targeting of FAK–Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells A Datta, N Bhasin, H Kim, M Ranjan, B Rider, ZY Abd Elmageed, ... Cancer letters 362 (1), 25-35, 2015 | 38 | 2015 |
Drivers of transcriptional variance in human intestinal epithelial organoids ZK Criss 2nd, N Bhasin, SC Di Rienzi, A Rajan, K Deans-Fielder, ... Physiological Genomics 53 (11), 486-508, 2021 | 25 | 2021 |
Vitamin D regulation of the uridine phosphorylase 1 gene and uridine-induced DNA damage in colon in African Americans and European Americans N Bhasin, D Alleyne, OA Gray, SS Kupfer Gastroenterology 155 (4), 1192-1204. e9, 2018 | 15 | 2018 |
Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors S Miller, N Bhasin, H Urrego, K Moroz, BG Rowan, MS Ramayya, ... International Journal of Oncology 42 (2), 627-634, 2013 | 10 | 2013 |
Inhibition of TRAP1 Accelerates the DNA damage response, activation of the heat shock response and metabolic reprogramming in colon cancer cells N Bhasin, P Dabra, L Senavirathna, S Pan, R Chen Frontiers in bioscience (Landmark edition) 28 (9), 227, 2023 | 3 | 2023 |
Deconstructing Organs: Single-Cell Analyses, Decellularized Organs, Organoids, and Organ-on-a-Chip Models: Drivers of transcriptional variance in human intestinal epithelial … ZK Criss 2nd, N Bhasin, SC Di Rienzi, A Rajan, K Deans-Fielder, ... Physiological Genomics 53 (11), 486, 2021 | 1 | 2021 |
DAD1 as potential therapeutic target and biomarker in prostate cancer N Bhasin Tulane University, 2015 | 1 | 2015 |
Significant Risk Medical Devices–Gastroenterology and Urology M Ranjan, P Dabral, N Khurana, N Bhasin Significant and Nonsignificant Risk Medical Devices, 179-203, 2024 | | 2024 |
Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers P Dabral, N Bhasin, M Ranjan, MM Makhlouf, ZY Abd Elmageed Cancers 16 (13), 2462, 2024 | | 2024 |
A complementary metaproteomic approach to interrogate microbiome cultivated from clinical colon biopsies VA Duong, A Enkhbayar, N Bhasin, L Senavirathna, EC Preisner, ... Proteomics, 2400078, 2024 | | 2024 |
Cancer stem cell–derived exosomes: what is known to date N Bhasin, P Dabral, K Selvendiran, M Anbalagan Cancer Stem Cells and Signaling Pathways, 591-607, 2024 | | 2024 |
Impact of gut microbial metabolites on colon epithelium N Bhasin, LH Senavirathna, M Bresson, L Zhe, VB Poplaski, ZA Lami, ... Cancer Research 83 (7_Supplement), 5299-5299, 2023 | | 2023 |
Patient-Derived Xenograft Models for Studying Vascular Mimicry in Melanoma In Vivo M Ranjan, N Bhasin Vasculogenic Mimicry: Methods and Protocols, 85-92, 2022 | | 2022 |
Metaproteomic analysis of IBD associated colorectal cancer N Bhasin, P Dabral, V Poplaski, L Lai, HY Tsai, M Bronner, T Brentnall, ... Cancer Research 82 (12_Supplement), 5078-5078, 2022 | | 2022 |
Orthopaedics MRN Bhasin Toxicological Aspects of Medical Device Implants, 257-278, 2020 | | 2020 |
Inter-Ethnic Differences in Colonic Response of Uridine Phosphorylase 1 (UPP1) to Vitamin D: Implications for Colorectal Cancer Disparities N Bhasin, D Alleyne, C Cham, SS Kupfer Gastroenterology 152 (5), S418, 2017 | | 2017 |
Stem-cell based selective delivery of alpha keto reductases for therapeutic targeting of residual androgens in prostate cancer M Ranjan, Z Abd Elmageed, H Kim, A Datta, N Bhasin, SE Braun, ... Cancer Research 75 (15_Supplement), 3537-3537, 2015 | | 2015 |